JB/CALL/POLE GROU/27.5/0.0667/21.06.24 | Market Closed - Swiss Exchange 08:50:00 16/05/2024 pm IST | ||
| 0.428 CHF | -4.04% |
|
| Current month | +36.31% | ||
| 1 month | +63.98% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
POLYPEPTIDE GROUP AG
Latest news about POLYPEPTIDE GROUP AG
More news
| Date | Price | Change |
|---|---|---|
| 16/24/16 | 0.428 | -4.04% |
| 15/24/15 | 0.446 | +8.52% |
| 14/24/14 | 0.411 | +5.12% |
| 13/24/13 | 0.391 | +1.82% |
| 10/24/10 | 0.384 | +20.00% |
Delayed Quote Swiss Exchange
Last update May 16, 2024 at 08:50 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | POLYPEPTIDE GROUP AG |
| Issuer | Bank Julius Bär |
| PPGNJB | |
| ISIN | CH1240056767 |
| Date issued | 04/01/2023 |
| Strike | 27.5 CHF |
| Maturity | 21/06/2024 (36 Days) |
| Parity | 14.99 : 1 |
| Emission price | 0.65 CHF |
| Emission volume | N/A |
| Settlement | both |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.75 CHF |
|---|---|
| Lowest since issue | 0.008 CHF |
| Spread | 0.01 CHF |
| Spread % | 2.34% |
Company Profile
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
Consensus: PolyPeptide Group AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
33.55
EUR
Average target price
25.12
EUR
Spread / Average Target
-25.12%
- Stock Market
- Warrants
- PPGNJB Warrant
